David Perry's most recent trade in Better Therapeutics Inc was a trade of 839,895 Common Stock done at an average price of $0.2 . Disclosure was reported to the exchange on Feb. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Better Therapeutics Inc | Perry David | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.19 per share. | 09 Feb 2024 | 839,895 | 2,416,634 | - | 0.2 | 160,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.17 per share. | 09 Jan 2024 | 1,471,453 | 1,576,739 | - | 0.2 | 250,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 3,750 | 105,286 | - | 0 | Common Stock | |
| Better Therapeutics Inc | David Perry | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 27 Jul 2023 | 1,233,045 | 13,030,393 | - | 0.7 | 900,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 10 Apr 2023 | 3,636,364 | 3,636,364 | - | 0.8 | 3,000,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 10 Apr 2023 | 1,333,333 | 11,797,348 | - | 0.8 | 1,100,000 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Sale of securities on an exchange or to another person at price $ 469.65 per share. | 06 Mar 2023 | 3,999 | 8,716 (0%) | 0% | 469.6 | 1,878,114 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 4,866 | 14,826 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 4,866 | 7,563 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.35 per share. | 16 Feb 2023 | 2,111 | 12,715 (0%) | 0% | 465.4 | 982,354 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,261 | 12,429 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman | David T Perry | Corporate Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 1,527 | 3,444 | - | - | Restricted Stock Rights | |
| Northrop Grumman | David T Perry | Corporate Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 1,527 | 10,438 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman | David T Perry | Corporate Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 464.28 per share. | 13 Feb 2023 | 478 | 9,960 (0%) | 0% | 464.3 | 221,926 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 15 Sep 2022 | 39,156 | 101,536 | - | 2.1 | 80,975 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 15 Sep 2022 | 10,844 | 62,380 | - | 2.0 | 21,623 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Sale of securities on an exchange or to another person at price $ 393.77 per share. | 24 Feb 2022 | 3,065 | 8,911 (0%) | 0% | 393.8 | 1,206,890 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,671 | 11,168 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,671 | 14,457 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 4,252 | 16,839 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 384.77 per share. | 15 Feb 2022 | 2,481 | 11,976 (0%) | 0% | 384.8 | 954,614 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,474 | 4,971 | - | - | Restricted Stock Rights | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 1,970 | 9,383 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 1,970 | 3,497 | - | - | Restricted Stock Rights | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 390.60 per share. | 14 Feb 2022 | 597 | 8,786 (0%) | 0% | 390.6 | 233,188 | Common Stock |
| Evelo Biosciences Inc | David Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 15,690 | 15,690 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | David Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 1,810 | 1,810 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 10,164,015 | 10,215,551 | - | - | Common Stock | |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 293,150 | 10,508,701 | - | - | Common Stock | |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 30 Apr 2021 | 200,000 | 10,730,037 | - | 10 | 2,000,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 30 Apr 2021 | 100,000 | 10,830,037 | - | 10 | 1,000,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 28,300 | 28,300 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 21,336 | 10,530,037 | - | - | Common Stock | |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 30 Apr 2021 | 20,000 | 51,536 | - | 10.0 | 199,000 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.94 per share. | 30 Apr 2021 | 8,000 | 31,536 | - | 9.9 | 79,520 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 30 Apr 2021 | 8,000 | 23,536 | - | 10.0 | 79,600 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.93 per share. | 30 Apr 2021 | 7,000 | 12,476 | - | 9.9 | 69,510 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.93 per share. | 30 Apr 2021 | 3,476 | 5,476 | - | 9.9 | 34,517 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.93 per share. | 30 Apr 2021 | 3,060 | 15,536 | - | 9.9 | 30,386 | Common Stock |
| Better Therapeutics Inc | David Perry | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 30 Apr 2021 | 2,000 | 2,000 | - | 10.0 | 19,900 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Sale of securities on an exchange or to another person at price $ 299.72 per share. | 26 Feb 2021 | 5,552 | 7,413 (0%) | 0% | 299.7 | 1,664,045 | Common Stock |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 4,513 | 16,346 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman | David T Perry | CVP Chief Global Bus Off | Sale of securities on an exchange or to another person at price $ 326.83 per share. | 07 Aug 2020 | 5,091 | 9,507 (0%) | 0% | 326.8 | 1,663,892 | Common Stock |